Boston Trust Walden Corp Medpace Holdings, Inc. Transaction History

Boston Trust Walden Corp

$13.5 Billion
Q1 2025

A detailed history of Boston Trust Walden Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 134,804 shares of MEDP stock, worth $40.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

134,804

Previous 134,575 0.17%

Holding current value

$40.2 Million

Previous $44.7 Million 8.13%

% of portfolio

0.31%

Previous 0.32%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	BUY	$304.69 - $360.97 $69,774 - $82,662	229 Added 0.17%	134,804 $41.1 Million
Q4 2024 Jan 24, 2025	BUY	$308.93 - $363.58 $1.52 Million - $1.79 Million	4,920 Added 3.79%	134,575 $44.7 Million
Q3 2024 Oct 24, 2024	SELL	$320.58 - $457.29 $9.07 Million - $12.9 Million	-28,296 Reduced 17.91%	129,655 $43.2 Million
Q2 2024 Jul 19, 2024	SELL	$372.0 - $424.34 $40.6 Million - $46.3 Million	-109,064 Reduced 40.85%	157,951 $65.1 Million
Q1 2024 Apr 22, 2024	SELL	$284.87 - $413.31 $63 Million - $91.4 Million	-221,256 Reduced 45.31%	267,015 $108 Million
Q4 2023 Jan 24, 2024	SELL	$227.52 - $312.68 $11.8 Million - $16.2 Million	-51,684 Reduced 9.57%	488,271 $150 Million
Q3 2023 Oct 18, 2023	SELL	$233.98 - $281.67 $2.33 Million - $2.8 Million	-9,952 Reduced 1.81%	539,955 $131 Million
Q2 2023 Jul 24, 2023	SELL	$187.26 - $240.17 $2.38 Million - $3.06 Million	-12,728 Reduced 2.26%	549,907 $132 Million
Q1 2023 Apr 19, 2023	BUY	$174.31 - $239.52 $2.65 Million - $3.64 Million	15,193 Added 2.78%	562,635 $106 Million
Q4 2022 Jan 20, 2023	SELL	$153.06 - $226.57 $23.2 Million - $34.4 Million	-151,618 Reduced 21.69%	547,442 $0
Q3 2022 Oct 19, 2022	BUY	$145.13 - $182.49 $1.49 Million - $1.88 Million	10,282 Added 1.49%	699,060 $110 Million
Q2 2022 Jul 22, 2022	BUY	$130.2 - $168.03 $1.79 Million - $2.32 Million	13,784 Added 2.04%	688,778 $103 Million
Q1 2022 Apr 20, 2022	BUY	$138.87 - $214.31 $25.9 Million - $40 Million	186,518 Added 38.18%	674,994 $110 Million
Q4 2021 Jan 21, 2022	SELL	$182.74 - $227.9 $7.29 Million - $9.1 Million	-39,915 Reduced 7.55%	488,476 $106 Million
Q3 2021 Oct 25, 2021	BUY	$170.18 - $198.21 $368,269 - $428,926	2,164 Added 0.41%	528,391 $100 Million
Q2 2021 Jul 22, 2021	SELL	$158.62 - $194.3 $2.68 Million - $3.28 Million	-16,891 Reduced 3.11%	526,227 $92.9 Million
Q1 2021 Apr 21, 2021	BUY	$132.02 - $168.26 $4.42 Million - $5.63 Million	33,488 Added 6.57%	543,118 $89.1 Million
Q4 2020 Jan 15, 2021	BUY	$109.38 - $149.19 $11.1 Million - $15.1 Million	101,346 Added 24.82%	509,630 $70.9 Million
Q3 2020 Oct 14, 2020	BUY	$92.95 - $130.61 $1.37 Million - $1.93 Million	14,749 Added 3.75%	408,284 $45.6 Million
Q2 2020 Jul 23, 2020	BUY	$68.08 - $95.68 $24.7 Million - $34.7 Million	362,970 Added 1187.53%	393,535 $36.6 Million
Q1 2020 Apr 21, 2020	BUY	$61.71 - $101.95 $1.89 Million - $3.12 Million	30,565 New	30,565 $2.24 Million

Others Institutions Holding MEDP

# of Institutions

625

Shares Held

25.7M

Call Options Held

74.3K

Put Options Held

79.1K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.27B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Medpace Holdings, Inc. Transaction History